Longitudinal validation of the phospholamban (PLN) p.Arg14del risk model

Back

ESC Professional Premium Access

Longitudinal validation of the phospholamban (PLN) p.Arg14del risk model

Session: Emerging role of genetic testing for ventricular arrhythmia management

Topic: Ion Channel Disorders

Speaker: Miss M. Van Der Heide (Amsterdam, NL)

Event: ESC Congress 2022

Congress Presentation

Add to my library

About the speaker

Miss Myrthe Van Der Heide

Amsterdam University Medical Centre, Amsterdam (Netherlands (The))

0 follower

4 more presentations in this session

SCN5A mutations and the role of genetic background in the pathophysiology of Brugada syndrome

Speaker: Professor V. Probst (Nantes, FR)

Natural History of Patients with Typical and Atypical Catecholaminergic Polymorphic Ventricular Tachycardia

Speaker: Doctor A. Trancuccio (Pavia, IT)

Calmodulinopathy is a common cause of critical cardiac phenotypes in fetus and infancy

Speaker: Doctor M. Fukuyama (Otsu, JP)

Efficacy and safety of the ICD in patients with catecholaminergic polymorphic ventricular tachycardia

Speaker: Assistant Professor A. Mazzanti (Pavia, IT)

Access the full session

Emerging role of genetic testing for ventricular arrhythmia management

Speakers: Miss M. Van Der Heide, Professor V. Probst, Doctor A. Trancuccio, Doctor M. Fukuyama, Assistant Professor A. Mazzanti

Access

About the event

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources